Ozempic and Wegovy maker Novo Nordisk should be forced to cut the price of its obesity and diabetes wonder drugs, Bernie Sanders has said, claiming the current costs are “outrageously high”. The US senator has written a column in Danish newspaper Politiken urging the public to put pressure on Novo Nordisk, which is the nation’s biggest business. The former Democratic presidential hopeful said Novo’s obesity jabs cost far more in the US than elsewhere in the world, suggesting this means Novo “does not live up to its high moral ideals”. Mr Sanders claimed Novo charges around 10 times more for Ozempic in the US than it does in some European countries. The treatment has been priced at $188 (£150) per month in Denmark, although it was reduced to $125 earlier this month. Mr Sanders has claimed the treatment costs $6,700 a month for an American. Mr Sanders wrote: “Help the American people do something about the obesity and diabetes epidemic we are facing.” Ozempic is a treatment for diabetes but can be prescribed off label for weight loss. Wegovy, which is also made by Novo, specifically targets weight loss. These drugs are part of a new generation of appetite suppressant...